Hawaii Employer-Union Health Benefits Trust Fund

Recent CVS plan changes include:

1. Added the RxSavingsPlus program to the EUTF and HSTA VB active plans effective July 1, 2022. This is a discount program where members can get additional discounts on certain non-covered drugs. (More information will soon be available on caremark.com/eutf.)
2. Added prior authorization and quantity limits under the EUTF active plans effective July 1, 2022 for Opzelura (treats atopic dermatitis) and eye drops used to treat presbyopia (farsightedness) such as Vuity.
3. Expanded the age limitation for colonoscopy prep prescription drugs to ages 45-75 under the EUTF and HSTA VB active plans effective May 1, 2022, in accordance with federal law.
4. Added the Drug Exclusion Plan Design program which excludes targeted drugs with little or no clinical value under the EUTF active plans effective January 1, 2022.
5. Added utilization management such as prior authorization, step-therapy, and/or quantity limits under the EUTF active plans effective January 1, 2022 for the following drugs or classes: Acthar (treats infantile spasms); Afrezza (treats diabetes), Mupirocin (treats bacterial infections); Omega-3 fatty acids (treats hyperlipidemia); Palforzia (treats peanut allergies); products for migraine, neuralgia, psoriasis, and rosacea; and topical corticosteroids.
6. Added prior authorization and quantity limit requirements for Ivermectin (treatment of parasitic infections) under the EUTF and HSTA VB active plans effective October 14, 2021.